Cargando…
PSUN199 SGLT2-Inhibitor Prescription Rates in Individuals with Diabetic Nephropathy at a Teaching Outpatient Clinic
INTRODUCTION: Type 2 diabetes mellitus is one of the leading causes of kidney failure worldwide. According to the CREDENCE trial published in June 2019, SGLT2 inhibitors have significant benefits in renal outcomes even in individuals with more advanced diabetic kidney disease specifically in terms o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625001/ http://dx.doi.org/10.1210/jendso/bvac150.788 |